BPGAM
ALXN

BTG Pactual Global Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

BTG Pactual Global Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-59,764
Closed -$11M – 184
2021
Q2 		$11M Buy
59,764
+13,000
+28% +$2.23M 2.88% 6
2021
Q1 		$7.15M Buy
46,764
+13,000
+39% +$2.01M 1.93% 9
2020
Q4 		$5.28M Buy
+33,764
New +$4.34M 0.74% 29
2018
Q4 		– Sell
-1,984
Closed -$276K – 78
2018
Q3 		$276K Sell
1,984
-3,077
-61% -$386K 0.12% 49
2018
Q2 		$628K Buy
5,061
+328
+7% +$38.3K 0.18% 50
2018
Q1 		$528K Buy
4,733
+966
+26% +$115K 0.14% 53
2017
Q4 		$450K Buy
3,767
+127
+3% +$15.5K 0.16% 41
2017
Q3 		$511K Sell
3,640
-228
-6% -$31K 0.16% 49
2017
Q2 		$471K Buy
3,868
+967
+33% +$113K 0.14% 54
2017
Q1 		$352K Buy
+2,901
New +$374K 0.13% 59
2014
Q3 		– Sell
-2,200
Closed -$344K – 278
2014
Q2 		$344K Buy
+2,200
New +$347K 0.05% 190

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

BTG Pactual Global Asset Management's ALXN Position: Q3 2021 in Review

BTG Pactual Global Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 59,764 shares — an estimated $11M sold.

BTG Pactual Global Asset Management first reported a position in ALXN in Q2 2014 and held it in 11 quarters. The position peaked at $11M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • BTG Pactual Global Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 59,764 Alexion Pharmaceuticals shares in Q3 2021, an estimated $11M.
  • BTG Pactual Global Asset Management first reported a position in Alexion Pharmaceuticals in Q2 2014 and held it in 11 quarters.
  • BTG Pactual Global Asset Management's Alexion Pharmaceuticals position peaked at $11M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on BTG Pactual Global Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.